Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692.
Second Propedeutic Department of Internal Medicine, School of Medicine, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.
Niki
N
Katsiki
Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London, London, U.K. mikhailidis@aol.com.
Dimitri P
DP
Mikhailidis
D002561:Cerebrovascular Disorders; D003924:Diabetes Mellitus, Type 2; D006801:Humans; D006943:Hyperglycemia; D007004:Hypoglycemic Agents; D007328:Insulin; D007333:Insulin Resistance; D000077205:Pioglitazone; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D007328:Insulin; D045162:Thiazolidinediones; D000077205:Pioglitazone